Pleocytosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
The commonest CSF finding was raised protein (n = 6) and a lymphocytic pleocytosis (n = 7).
|
28101825 |
2017 |
Pleocytosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
The CSF formula typically shows a lymphocytic pleocytosis, and low glucose and high protein concentrations.
|
28281443 |
2017 |
Pleocytosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
MRI study most often presented different enhancing lesions and the CSF analysis commonly revealed a lymphocytic pleocytosis and raised proteins.
|
28716286 |
2017 |
Pleocytosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
However, in this case, CSF analysis revealed an exaggerated pleocytosis (72 white blood cells (WBC)/mm<sup>3</sup>).
|
29306858 |
2018 |
Pleocytosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
CSF examination showed mild pleocytosis and elevated protein, and negative oligoclonal bands.
|
29312139 |
2017 |
Pleocytosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
The absence of pleocytosis or increased proteins in the CSF was associated with a longer time from symptom onset to diagnosis and treatment (p = 0.003).
|
29364387 |
2018 |
Pleocytosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
CSF samples that demonstrated an eosinophilic pleocytosis had the highest levels of ECs, exceeding those with neutrophilic pleocytosis, suggesting that ECs have a major effect on migration of eosinophils in the CSF.
|
29408878 |
2018 |
Pleocytosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Investigation showed: raised CSF protein; pleocytosis; raised CSF:peripheral blood mononuclear cell HTLV-1 proviral load ratio; and MRI either normal or showing white matter changes in brain and cord.
|
29423617 |
2018 |
Pleocytosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Repeated CSF analysis revealed a slightly lymphocytic predominant pleocytosis and positive anti-NMDAR antibody.
|
29443773 |
2018 |
Pleocytosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Additionally, CSF studies showed the transition from a neutrophilic pleocytosis to a lymphocytic pleocytosis suggesting an inflammatory component.
|
29483006 |
2018 |
Pleocytosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
It has been estimated that paediatric meningitis without elevated CSF white cell count (pleocytosis) accounts for 0.5-12% of all cases of bacterial meningitis.
|
29540199 |
2018 |
Pleocytosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
CSF analysis most consistently shows a lymphocytic pleocytosis and elevated proteins.
|
29770929 |
2018 |
Pleocytosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Patients with headache had more frequently fever (14/22 [64%] vs. 2/12 [17%] p = 0.013) and higher CSF pleocytosis (median white blood cells 79/μl [range, 6-311/μl] vs. 30/μl [range, 2-69/μl], p = 0.035) than those without headache, but there was no difference in gender, age at onset, seizure, migraine, CSF oligoclonal band detection, elevated IgG index, tumor association, or brain MRI abnormalities between them.
|
29856136 |
2018 |
Pleocytosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
VRI was defined as one or more positive CSF cultures or Gram stain with CSF pleocytosis and biochemical abnormalities.
|
29932377 |
2018 |
Pleocytosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
CSF showed mildly elevated opening pressure and lymphocytic pleocytosis and a diagnosis of aseptic meningitis was considered.
|
30300850 |
2019 |
Pleocytosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
CSF analysis showed elevated protein of 511 and normal glucose of 104 (67% serum), with lymphocytic pleocytosis (25 cells, 96% lymphocytes).
|
30430892 |
2019 |
Pleocytosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
CSF abnormalities usually involved mild pleocytosis.
|
30482402 |
2019 |
Pleocytosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Moderately increased pleocytosis in CSF (5-100 × 10<sup>6</sup>/L) further increased the diagnostic accuracy of this combination, AUC 0.90 (95% CI, 0.81-0.98).
|
30669985 |
2019 |
Pleocytosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
There were no differences between CSF protein, CSF neutrophilic pleocytosis, and serum C-reactive protein between cases and controls (P > 0.1).
|
30708338 |
2019 |
Pleocytosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
CNS viral escape should be considered as a differential among patients on Atazanavir presenting with non-focal cerebral syndrome and CSF lymphocytic pleocytosis.
|
30951880 |
2019 |
Pleocytosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
The CSF profile mostly showed mononuclear pleocytosis (64%), high protein (93%) and normal glucose (66%).
|
31022232 |
2019 |
Pleocytosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
CSF showed a monocytic pleocytosis and tested positive for GABA<sub>B</sub> receptor autoantibodies.
|
31062226 |
2019 |